Isolation of a novel gene, TSP50, by a hypomethylated DNA fragment in human breast cancer

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3215-3221

  Yuan, Liming ^a   Shan, Jidong ^a   De Risi, Dwight ^a   Broome, John ^a   Lovecchio, John ^a   Gal, David ^a   Vinciguerra, Vincent ^a   Hao Peng, Xu ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Molecular Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER TISSUE; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION; GENE ISOLATION; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING; TESTIS; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, NORTHERN; BREAST; BREAST NEOPLASMS; CATHEPSINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; CYSTEINE ENDOPEPTIDASES; DNA METHYLATION; DNA PROBES; DNA, NEOPLASM; FEMALE; GENE LIBRARY; HUMANS; MALE; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; OVARY; POLYMERASE CHAIN REACTION; REFERENCE VALUES; TESTIS;

EID: 0033168044     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Shaw, D. J., Chaudhary, S., Rundle, S. A., Crow, S., Brook, J. D., Harper, P. S., and Harley, H. A study of DNA methylation in myotonic dystrophy. J. Med. Genet., 30: 189-192, 1993.
2. Laird, P. W., and Jaenisch, R. DNA methylation and cancer. Hum. Mol. Genet., 3: 1487-1485, 1994.
3. Riggs, D. A. 5-Methylcytosine, gene regulation, and cancer. In: J. P. Jost and H. P. Saluz (eds.), DNA Methylation: Molecular Biology and Biological Significance, pp. 1-30. Basel, Switzerland: Birkhauser Verlag, 1993.
4. Spruck, H. C., III, Rideout, M. W., III, and Jones, A. P. DNA methylation and cancer. In: J. P. Jost and H. P. Saluz (eds.), DNA Methylation: Molecular Biology and Biological Significance, pp. 487-509. Basel, Switzerland: Birkhauser Verlag, 1993.
5. Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Jung, W. E., Li, E., Weinberg, R. A., and Jaenisch, R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell, 81: 197-205, 1995.
6. Counts, J. L., and Goodman, J. I. Alteration in DNA methylation may play a variety of roles in carcinogenesis. Cell, 83: 13-15, 1995.
7. Baylin, S. B., Herman, J. M., Graff, J. R., Vertino, P. M., and Issa, J-P. Alterations in DNA methylation. A fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
8. Bird, P. A. CpG islands as gene markers in the vertebrate nucleus. Trends Genet., 3: 342-346, 1987.
9. Larsen, F., Gunderson, G., Lopez, R., and Prydz, H. CpG island as gene markers in the human genome. Genomics, 13: 1095-1107, 1992.
10. Adams, R. L., and Buron, R. H. DNA methylation in eukaryotes. CRC Crit Rev. Biochem., 13: 349-384, 1982.
11. Antequera, F., and Bird, P. A. CpG islands. In: J. P. Jost and H. P. Saluz (eds.), DNA Methylation: Molecular Biology and Biological Significance, pp. 169-185. Basel, Switzerland: Birkhauser Verlag, 1993.
12. Bird, P. A. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
13. Gardiner, K. Base composition and gene distribution: critical patterns in mammalian genome organization. Trends Genet., 12: 519-524, 1996.
14. Lisitsyn, N., Lisitsyn, N., and Wigler, M. Cloning the differences between two complex genomes. Science (Washington DC), 259: 946-951, 1993.
15. Cedar, H., Solage, A., Glaser, G., and Razin, A. Direct detection of methylated cytosine in DNA by use of the restriction enzyme. Msp 1. Nucleic Acids Res., 6: 2125-2133, 1979.
16. mCGG is resistant to Msp1 cleavage. Nucleic Acids Res., 11: 3559-3569, 1983.
17. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.
18. Weng, A., Engler, P., and Storb, U. The bulk chromatin structure of a murine transgene does not vary with its transcriptional or DNA methylation status. Mol. Cell. Biol., 15: 572-579, 1995.
19. Bishop, D. T., Williamson, A. J., and Skolnick, H. M. A model for restriction length distributions. Am. J. Hum. Genet., 35: 795-815, 1983.
20. Sambrook, J., Fritsch, E. F., and Maniatis, T. In: N. Ford, C. Nolan, and M. Ferguson (eds.), Molecular Cloning Manual, pp. 9.16-9.19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
21. Walter, M. A., Spillett, D. J., Thomas, P., Weissenbach, J., and Goodfellow, P. N. A method for constructing radiation hybrid maps of whole genomes. Nat. Genet., 7: 22-28, 1994.
22. Bird, A. Gene number, noise reduction and biological complexity. Trends Genet., 11: 94-100, 1995.
23. Kass, S. U., Pruss, D., and Wolffe, A. P. How does DNA methylation repress transcription? Trends Genet., 13: 444-449, 1997.
24. Siegfried, Z., and Cedar, H. DNA methylation: a molecular lock. Curr. Biol., 7: R305-R307, 1997.
25. Nelson, M., and McClelland, M. Site-specific methylation: effect on DNA methylation methyltransferases and restriction endonucleases. Nucleic Acids Res., 19: 2045-2071, 1991.
26. Yeivin, A., and Razin, A. Gene methylation patterns and expression. In: J. P. Jost and H. P. Saluz (eds.), DNA Methylation: Molecular Biology and Biological Significance, pp 523-568. Basel, Switzerland: Birkhauser Verlag, 1993.
27. Cheah, M. S., Wallace, C. D., and Hoffman, R. M. Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J. Natl. Cancer Inst., 73: 1057-1065, 1984.
28. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., and Reed, J. C. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82: 1820-1828, 1993.
29. Ray, J. S., Harbison, M. L., McClain, R. M., and Goodman, J. I. Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumor. Mol. Carcinog., 9: 155-166, 1994.
30. Vorce, R. L., and Goodman, J. I. Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors. Toxicol. Appl. Pharmacol., 100: 398-410, 1989.
31. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D-S. R., Gnarra, J. R., Linehan, M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
32. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
33. INK4B1. Cancer Res., 56: 722-727, 1996.
34. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., and Baylin, S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55: 5195-5199, 1995.
35. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J-P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
36. Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B., and Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem., 272: 22322-22329, 1997.
37. Razin, A., and Kafri, T. DNA methylation from embryo to adult. Prog. Nucleic Acid Res. Mol. Biol., 48: 53-58, 1994.
38. Martienssen, R. A., and Richards, E. J. DNA methylation in eukaryotes. Curr. Opin. Genet. Dev., 5: 234-242, 1995.